PO-82 Impede VTE vs saved scores to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma with immunomodulatory drugs: how to choose?

Authors :: S. Sotton
Bernard Tardy
H. Thollot
P. Moreau
Fabien Tinquaut
Ismail Elalamy
X. Leleu
Emilie Chalayer
C. Hulin
J.P. Fermand
A. Teste
Denis Guyotat
Source :: Thrombosis Research. 200:S61-S62
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: medicine.medical_specialty
business.industry
Internal medicine
medicine
Hematology
Newly diagnosed
business
medicine.disease
Venous thromboembolism
Multiple myeloma

Full Text Access

Tools